Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2928 | 2112 | 31.1 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
14 | 4 | ORTHOPEDICS//DENTISTRY, ORAL SURGERY & MEDICINE//SPORT SCIENCES | 808941 |
333 | 3 | MIGRAINE//HEADACHE//CEPHALALGIA | 37708 |
232 | 2 | MIGRAINE//HEADACHE//CEPHALALGIA | 20277 |
2928 | 1 | TRIPTANS//SUMATRIPTAN//MIGRAINE | 2112 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TRIPTANS | authKW | 2092762 | 13% | 53% | 272 |
2 | SUMATRIPTAN | authKW | 1805377 | 14% | 41% | 303 |
3 | MIGRAINE | authKW | 1203415 | 39% | 10% | 816 |
4 | RIZATRIPTAN | authKW | 1059117 | 5% | 72% | 102 |
5 | ALMOTRIPTAN | authKW | 987969 | 4% | 84% | 81 |
6 | ZOLMITRIPTAN | authKW | 805277 | 4% | 59% | 95 |
7 | ELETRIPTAN | authKW | 518445 | 2% | 78% | 46 |
8 | HEADACHE | journal | 502786 | 18% | 9% | 386 |
9 | CEPHALALGIA | journal | 327440 | 14% | 8% | 288 |
10 | 5 HT1B 1D RECEPTOR AGONIST | authKW | 323809 | 1% | 80% | 28 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 30289 | 52% | 0% | 1095 |
2 | Neurosciences | 3173 | 24% | 0% | 510 |
3 | Pharmacology & Pharmacy | 2722 | 23% | 0% | 479 |
4 | Emergency Medicine | 2502 | 5% | 0% | 101 |
5 | Medicine, General & Internal | 1198 | 12% | 0% | 262 |
6 | Primary Health Care | 210 | 1% | 0% | 23 |
7 | Psychiatry | 190 | 5% | 0% | 96 |
8 | Health Policy & Services | 153 | 2% | 0% | 35 |
9 | Health Care Sciences & Services | 118 | 2% | 0% | 43 |
10 | Chemistry, Analytical | 43 | 4% | 0% | 75 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | KINGS HEADACHE SERV | 115949 | 1% | 42% | 19 |
2 | HEADACHE CARE | 103253 | 0% | 71% | 10 |
3 | GOTHENBURG MIGRAINE CLIN | 59024 | 0% | 58% | 7 |
4 | JEFFERSON HEADACHE | 48016 | 1% | 13% | 25 |
5 | SOCIALA HUSET | 45172 | 0% | 63% | 5 |
6 | WS3C 90 | 43369 | 0% | 100% | 3 |
7 | WS3C90 | 43369 | 0% | 100% | 3 |
8 | HEADACHE | 39696 | 2% | 6% | 43 |
9 | HEADACHE RIO | 38547 | 0% | 67% | 4 |
10 | NEUROL PSYCHIAT THER EUT DEV GRP | 32525 | 0% | 75% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HEADACHE | 502786 | 18% | 9% | 386 |
2 | CEPHALALGIA | 327440 | 14% | 8% | 288 |
3 | HEADACHE QUARTERLY-CURRENT TREATMENT AND RESEARCH | 60183 | 1% | 14% | 30 |
4 | CNS DRUGS | 11902 | 2% | 2% | 38 |
5 | JOURNAL OF HEADACHE AND PAIN | 9009 | 1% | 3% | 22 |
6 | CONFINIA CEPHALALGICA | 8101 | 0% | 7% | 8 |
7 | EUROPEAN NEUROLOGY | 6466 | 2% | 1% | 40 |
8 | CLINICAL THERAPEUTICS | 3936 | 2% | 1% | 37 |
9 | NEUROLOGY | 3435 | 3% | 0% | 72 |
10 | NERVENHEILKUNDE | 2687 | 1% | 1% | 20 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TRIPTANS | 2092762 | 13% | 53% | 272 | Search TRIPTANS | Search TRIPTANS |
2 | SUMATRIPTAN | 1805377 | 14% | 41% | 303 | Search SUMATRIPTAN | Search SUMATRIPTAN |
3 | MIGRAINE | 1203415 | 39% | 10% | 816 | Search MIGRAINE | Search MIGRAINE |
4 | RIZATRIPTAN | 1059117 | 5% | 72% | 102 | Search RIZATRIPTAN | Search RIZATRIPTAN |
5 | ALMOTRIPTAN | 987969 | 4% | 84% | 81 | Search ALMOTRIPTAN | Search ALMOTRIPTAN |
6 | ZOLMITRIPTAN | 805277 | 4% | 59% | 95 | Search ZOLMITRIPTAN | Search ZOLMITRIPTAN |
7 | ELETRIPTAN | 518445 | 2% | 78% | 46 | Search ELETRIPTAN | Search ELETRIPTAN |
8 | 5 HT1B 1D RECEPTOR AGONIST | 323809 | 1% | 80% | 28 | Search 5+HT1B+1D+RECEPTOR+AGONIST | Search 5+HT1B+1D+RECEPTOR+AGONIST |
9 | FROVATRIPTAN | 319174 | 2% | 60% | 37 | Search FROVATRIPTAN | Search FROVATRIPTAN |
10 | NARATRIPTAN | 267612 | 2% | 51% | 36 | Search NARATRIPTAN | Search NARATRIPTAN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | XU, HY , HAN, W , WANG, JH , LI, MX , (2016) NETWORK META-ANALYSIS OF MIGRAINE DISORDER TREATMENT BY NSAIDS AND TRIPTANS.JOURNAL OF HEADACHE AND PAIN. VOL. 17. ISSUE . P. - | 98 | 88% | 0 |
2 | TFELT-HANSEN, P , DE VRIES, P , SAXENA, PR , (2000) TRIPTANS IN MIGRAINE - A COMPARATIVE REVIEW OF PHARMACOLOGY, PHARMACOKINETICS AND EFFICACY.DRUGS. VOL. 60. ISSUE 6. P. 1259 -1287 | 104 | 75% | 277 |
3 | MARMURA, MJ , SILBERSTEIN, SD , SCHWEDT, TJ , (2015) THE ACUTE TREATMENT OF MIGRAINE IN ADULTS: THE AMERICAN HEADACHE SOCIETY EVIDENCE ASSESSMENT OF MIGRAINE PHARMACOTHERAPIES.HEADACHE. VOL. 55. ISSUE 1. P. 3 -20 | 53 | 85% | 33 |
4 | WORTHINGTON, I , PRINGSHEIM, T , GAWEL, MJ , GLADSTONE, J , COOPER, P , DILLI, E , AUBE, M , LEROUX, E , BECKER, WJ , (2013) TARGETED REVIEW: MEDICATIONS FOR ACUTE MIGRAINE TREATMENT.CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. VOL. 40. ISSUE 5. P. S10-S32 | 79 | 88% | 1 |
5 | HOUGAARD, A , TFELT-HANSEN, P , (2010) ARE THE CURRENT IHS GUIDELINES FOR MIGRAINE DRUG TRIALS BEING FOLLOWED?.JOURNAL OF HEADACHE AND PAIN. VOL. 11. ISSUE 6. P. 457-468 | 119 | 63% | 1 |
6 | JANKNEGT, R , (2007) TRIPTANS IN THE TREATMENT OF MIGRAINE: DRUG SELECTION BY MEANS OF THE SOJA METHOD.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 8. ISSUE . P. S15-S30 | 80 | 95% | 5 |
7 | FERRARI, MD , GOADSBY, PJ , ROON, KI , LIPTON, RB , (2002) TRIPTANS (SEROTONIN, 5-HT1B/1D AGONISTS) IN MIGRAINE: DETAILED RESULTS AND METHODS OF A META-ANALYSIS OF 53 TRIALS.CEPHALALGIA. VOL. 22. ISSUE 8. P. 633-658 | 76 | 84% | 267 |
8 | DERRY, CJ , DERRY, S , MOORE, RA , (2012) SUMATRIPTAN (ORAL ROUTE OF ADMINISTRATION) FOR ACUTE MIGRAINE ATTACKS IN ADULTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 2. P. - | 78 | 76% | 7 |
9 | DIENER, HC , YOON, MS , LIMMROTH, V , (2005) SPECIFIC TREATMENT OF MIGRAINE ATTACKS: ERGOTS AND TRIPTANS.AKTUELLE NEUROLOGIE. VOL. 32. ISSUE 8. P. 451-+ | 82 | 86% | 0 |
10 | ORR, SL , FRIEDMAN, BW , CHRISTIE, S , MINEN, MT , BAMFORD, C , KELLEY, NE , TEPPER, D , (2016) MANAGEMENT OF ADULTS WITH ACUTE MIGRAINE IN THE EMERGENCY DEPARTMENT: THE AMERICAN HEADACHE SOCIETY EVIDENCE ASSESSMENT OF PARENTERAL PHARMACOTHERAPIES.HEADACHE. VOL. 56. ISSUE 6. P. 911 -940 | 54 | 90% | 1 |
Classes with closest relation at Level 1 |